Biogen Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7.5
Buy
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
BIIB
Clean balance sheet with low leverage (0.4× debt-to-equity).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $212.51 (+10.8%)
29 analysts
HOLD
Target $29.00 (+8.3%)
27 analysts
Fundamentals
BIIB
PFE
20.7×
Trailing P/E
19.7×
12.0×
Forward P/E
9.5×
13.8%
Profit Margin
12.4%
78.7%
Gross Margin
75.8%
7.7%
ROE
8.9%
1.9%
Revenue Growth
-1.2%
31.1%
Earnings Growth
—
0.16
Beta
0.39
—
Price / Book
—
$28.3B
Market Cap
$152.4B
$115 – $202
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.